Therapeutic Asset Ratings
748 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cldn6 Urna-Lpx/Cldn6 Modrna-Lpx
Neoplasm
BioNTech Cell & Gene Therapies GmbH
P1
C
(36)
Dpx-Survivac
Breast Cancer
Providence Health & Services
P1
C
(36)
esr1 peptide vaccine
Breast Cancer
Herbert Lyerly
P1
C
(36)
Fluzone Quadrivalent
Breast Cancer
Rush University Medical Center
P1
C
(36)
Grt-C903
Breast Cancer
National Cancer Institute (NCI)
P1
C
(36)
Grt-C903
Ovarian Cancer
National Cancer Institute (NCI)
P1
C
(36)
Grt-R904
Breast Cancer
National Cancer Institute (NCI)
P1
C
(36)
Grt-R904
Ovarian Cancer
National Cancer Institute (NCI)
P1
C
(36)
her2 vaccine
Breast Cancer
Pravin T.P Kaumaya
P1
C
(36)
imp3-sarna vaccine
Non-Small Cell Lung Carcinoma
West China Hospital
P1
C
(36)
Kras Peptide Vaccine
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
C
(36)
Kras Peptide Vaccine
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
C
(36)
Lm-Gucy2C Vaccine
Colorectal Cancer
Thomas Jefferson University
P1
C
(36)
Neovax
Ovarian Cancer
Dana-Farber Cancer Institute
P1
C
(36)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Non-Small Cell Lung Carcinoma
Washington University School of Medicine
P1
C
(36)
Ovm-200
Ovarian Cancer
Oxford Vacmedix UK Ltd.
P1
C
(36)
Ovm-200
Prostate Cancer
Oxford Vacmedix UK Ltd.
P1
C
(36)
Pgv-001
Prostate Cancer
Ashutosh Kumar Tewari
P1
C
(36)
Pooled Mutant Kras-Targeted Long Peptide Vaccine 0. Each; 1. Total Peptides
Non-Small Cell Lung Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
C
(36)
Pvx-410
Breast Cancer
Massachusetts General Hospital
P1
C
(36)
Radvax
Neoplasm
Vaxine Pty Ltd
P1
C
(36)
Tgfβ-B-15 Peptide
Pancreatic Neoplasm
Inna Chen, MD
P1
C
(36)
Vsv-Gp128
Colorectal Cancer
Amal Therapeutics
P1
C
(36)
Personalized Neoantigen Mrna Tumor Vaccine
Solid Tumor Malignancies
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Early P1
C
(36)
Hepatitis A Vaccine
Urinary Bladder Carcinoma
National Cancer Institute (NCI)
P2
C
(35)
Showing 676 to 700 of 748 assets
Previous
Page 28 of 30
Next
